Topic Paragraphs
FDA Accomplishments for the American People
FDA Seizes 7-OH Opioids to Protect American Consumers
The U.S. Food and Drug Administration, in coordination with the U.S. Department of Justice, announced today that the U.S. Marshals Service seized approximately 73,000 units of 7-hydroxymitragynine (7-OH) products—valued at roughly $1 million—from three firms in Missouri.
Read MoreRecalls, Market Withdrawals, & Safety Alerts
Alerting you to the latest recalls of potentially unsafe FDA-regulated products gathered from press releases and other public notices. Not all recalls have press releases or are posted on this website.
Jan 28
Why Not Natural, Houston, Texas, is Recalling its Why Not Natural Organic Moringa - Green Superfood because of Possible Health Risk
Food & Beverages
Jan 28
Akkarco LLC Recalls Product Due to Possible Health Risk
Food & Beverages
Jan 28
Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution
Animal & Veterinary
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
A Special Year, New Seal, and Renewed Commitment to the American People
The FDA has unveiled an official agency seal which signifies the many public health strides made over 120 years.
FDA Encourages Development of New, Reliable Alternatives to Animal Testing in Sunscreen
FDA strongly encourages companies to continue to develop new, reliable ways to minimize animal testing.
FDA Focuses on Closing the Clinical Trial Reporting Gap for Research Integrity
The FDA is committed to ensuring data transparency by promoting timely registration and reporting of results information to ClinicalTrials.gov.
Recently Published Guidances
Feb 03
Computer Software Assurance for Production and Quality Management System Software
Medical Devices
Feb 03
Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions
Biologics, Medical Devices
Jan 29
Clinical Decision Support Software
Biologics, Drugs, Medical Devices